Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | RCAT | Common Stock | 83.1K | Nov 27, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | RCAT | Stock Options (buy) | Nov 27, 2024 | Common Stock | 31.7K | $2.61 | Direct | F1 | ||||||
holding | RCAT | Stock Options (buy) | Nov 27, 2024 | Common Stock | 20.8K | $1.27 | Direct | F2 | ||||||
holding | RCAT | Stock Options (buy) | Nov 27, 2024 | Common Stock | 6.67K | $0.98 | Direct | F3 | ||||||
holding | RCAT | Stock Options (buy) | Nov 27, 2024 | Common Stock | 41.7K | $1.29 | Direct | F4 |
Id | Content |
---|---|
F1 | Upon issue. |
F2 | On 2/8/2023, options to purchase 50,000 shares of Issuer's common stock were issued to Reporting Person. The options vest in equal quarterly amounts over a three-year period from the date of grant. As of the date hereof, options to purchase 20,834 of Issuers common stock remain outstanding, and are unvested. |
F3 | On 8/8/2023, options to purchase 10,000 shares of Issuer's common stock were issued to Reporting Person. The options vest in equal annual amounts over a three-year period from the date of grant. As of the date hereof, options to purchase 6,667 of Issuers common stock remain outstanding, and are unvested. |
F4 | On 7/10/2024, options to purchase 50,000 shares of Issuer's common stock were issued to Reporting Person. The options vest in equal quarterly amounts over a three-year period from the date of grant. As of the date hereof, options to purchase 41,667 of issuers common stock remain outstanding, and are unvested. |